Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications
Pharmaceutics · 18.08.2023 · 15 (8) · 2156
DOI: 10.3390/pharmaceutics15082156 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 18.08.2023. Verfasst von Chiara Ceresa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biosurfactants (BSs) are microbial compounds that have emerged as potential alternatives to chemical surfactants due to their multifunctional properties, sustainability and biodegradability. Owing to their amphipathic nature and distinctive structural arrangement, biosurfactants exhibit a range of physicochemical properties, including excellent surface activity, efficient critical micelle concentration, humectant properties, foaming and cleaning abilities and the capacity to form microemulsions. Furthermore, numerous biosurfactants display additional biological characteristics, such as antibacterial, antifungal and antiviral effects, and antioxidant, anticancer and immunomodulatory activities. Over the past two decades, numerous studies have explored their potential applications, including pharmaceuticals, cosmetics, antimicrobial and antibiofilm agents, wound healing, anticancer treatments, immune system modulators and drug/gene carriers. These applications are particularly important in addressing challenges such as antimicrobial resistance and biofilm formations in clinical, hygiene and therapeutic settings. They can also serve as coating agents for surfaces, enabling antiadhesive, suppression, or eradication strategies. Not least importantly, biosurfactants have shown compatibility with various drug formulations, including nanoparticles, liposomes, micro- and nanoemulsions and hydrogels, improving drug solubility, stability and bioavailability, and enabling a targeted and controlled drug release. These qualities make biosurfactants promising candidates for the development of next-generation antimicrobial, antibiofilm, anticancer, wound-healing, immunomodulating, drug or gene delivery agents, as well as adjuvants to other antibiotics. Analysing the most recent literature, this review aims to update the present understanding, highlight emerging trends, and identify promising directions and advancements in the utilization of biosurfactants within the pharmaceutical and biomedical fields.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy.
- School of Science, Engineering and Environment, University of Salford, Manchester M5 4WT, UK.
- Pharmaceutical Science Research Group, Biomedical Science Research Institute, Ulster University, Coleraine BT52 1SA, UK.
ORCID-Profile: Letizia Fracchia, Andrea Chiara Sansotera, Ibrahim M Banat
Zitieren
APA
Ceresa, C., Fracchia, L., Sansotera, A. C., De Rienzo, M. A. D., & Banat, I. M. (2023). Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications. Pharmaceutics, 15(8), 2156. https://doi.org/10.3390/pharmaceutics15082156
Vancouver
Ceresa C, Fracchia L, Sansotera AC, De Rienzo MAD, Banat IM. Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications. Pharmaceutics. 2023;15(8):2156. doi:10.3390/pharmaceutics15082156
BibTeX
@article{Ceresa2023,
author = {Ceresa, Chiara and Fracchia, Letizia and Sansotera, Andrea Chiara and De Rienzo, Mayri Alejandra Díaz and Banat, Ibrahim M},
title = {Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {8},
pages = {2156},
doi = {10.3390/pharmaceutics15082156}
}
EUVIMED